Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom.
Lim SH, Gros B, Sharma E, Lehmann A, Lindsay JO, Caulfield L, Gaya DR, Taylor J, Limdi J, Kwok J, Shuttleworth E, Dhar A, Burdge G, Selinger C, Cococcia S, Murray C, Balendran K, Raine T, George B, Walker G, Aldridge R, Irving P, Lees CW, Samaan M.
Lim SH, et al. Among authors: sharma e.
Inflamm Bowel Dis. 2024 Aug 1;30(8):1284-1294. doi: 10.1093/ibd/izad166.
Inflamm Bowel Dis. 2024.
PMID: 37603730